SAM #Notice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)

CDC Sole Source Contract for Valley Fever Diagnostic Research Services

This opportunity is a sole source procurement by the CDC's Mycotic Diseases Branch for applied research services to develop and validate diagnostic methods for coccidioidomycosis (Valley Fever). - Sole source contract to Valley Fever Solutions, Inc. and Valley Fever Center for Excellence (University of Arizona) - Scope includes: - Expansion and utilization of biospecimen repository - Development and evaluation of serologic diagnostic assays (including recombinant antigen production and ELISA prototype) - Validation of laboratory methods for detecting prior infection (PBMC-based stimulation assays, flow cytometry, CLIA-compliant) - Additional specimen collection and storage (including procurement of laboratory freezer) - Data analysis, reporting, and coordination for public health research - No specific product part numbers or hardware; focus is on research and laboratory services - Estimated contract value is $349,900 - Place of performance: Valley Fever Center for Excellence facilities, United States - NAICS code: 541715 (R&D in Physical, Engineering, and Life Sciences except Nanotechnology and Biotechnology) - Product/Service Code: AN12 (Health R&D Services; Applied Research) - Period of performance: September 30, 2026 to September 29, 2027 (one year) - Quarterly progress reports and final technical report required - Sole source justification based on unique expertise, biospecimen repository, and clinical infrastructure

Description

Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price to Valley fever Solutions, INC, Valley Fever Center for Excellence (University of Arizona) to support the development, evaluation, and validation of diagnostic methods for coccidioidomycosis through collaboration with the Valley Fever Center for Excellence (VFCE). This project will leverage VFCE’s existing biospecimen repository and clinical infrastructure to support diagnostic assay development. Additional specimen collection and enhanced storage capacity will be implemented to support expanded research needs.

 Product or Service Code: AN12 – Health R&D Services; Applied Research

NAICS Code: 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

The anticipated period of performance is September 30, 2026, to September 29, 2027

Place of Performance: All work under this contract shall be performed at the contractor’s facilities, specifically the Valley Fever Center for Excellence (VFCE), located within the United States. No work will be performed at CDC facilities.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to Contract Specialist at dwb7@cdc.gov by 11:00AM (ET) on 07/29/2026.

View original listing